Micafungin Pharmacodynamics Predict Clinical Outcomes in Hospitalized Patients with Candidemia caused by certain Candida species.

Ahmed ZakiAnne J Gonzales-LunaNicholas D BeydaTodd LascoKevin W Garey

Published in: Pharmacotherapy (2023)

CART-derived micafungin MIC and AUC/MIC breakpoints predicted patient mortality and treatment failure for certain Candida species. These results support the need for further PK/PD studies to optimize echinocandin dosing and improve patient outcomes.

Keyphrases

candida albicans
biofilm formation
case report
cardiovascular events
type diabetes
risk factors
coronary artery disease
escherichia coli
combination therapy
case control
staphylococcus aureus